📰 Mouse Model News
Page 5 - Mouse Model News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mouse Model. Real-time updates on events, politics, business and more.
June 7, 2023
07.06.2023 - Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that preclinical data from Enanta’s out-licensing portfolio has been accepted for a ...
May 31, 2023
About two-thirds of the risk for Alzheimer's disease (AD) is thought to arise from genetic influences, but about a third could be influenced by environment and lifestyle, opening the door for behavioral interventions that could delay or prevent pathophysiological changes that occur with AD.
May 24, 2023
MyJournals.org - Science - [ASAP] Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer (Journal of Proteome Research)
May 2, 2023
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting, taking...
April 26, 2023
Mostafa Nasr, PhD candidate, discusses the development of novel preclinical models of prostate cancer dormancy, and the significance of these outcomes may have on future research in metastatic prostate cancer.
April 19, 2023
19.04.2023 - TNF is involved in the development of Alzheimer’s Disease pathology following traumatic brain injury and is prevented by neutralization of soluble TNF by XPRO Boca Raton, Florida, April 19, 2023 (GLOBE NEWSWIRE) - INmune Bio, Inc. (NASDAQ: INMB) ... Seite 1
April 12, 2023
Bisiayo Fashemi, PhD, discusses how the addition of entinostat to olaparib could help combat PARP inhibitor-resistance in homologous recombination proficient ovarian cancer, as well as the clinical significance of utilizing mouse organoid models to investigate such strategies.
April 12, 2023
Catherine John, MD, discusses the antitumor effects of sulindac on the prevention and treatment of obesity-driven models of endometrial cancer.
March 29, 2023
Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx in patients with recurrent pericarditis - a debilitating heart disease
March 29, 2023
Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart... | March 29, 2023